Japan Medical Dynamic Marketing, Inc. (7600) AI Stock Analysis

• Market Cap: ¥14.59B
• Dividend Yield: 2.72%
• Average Volume (3M): 92.19K
• Price to Earnings (P/E): 10.2
• Beta (1Y): 0.54
• Revenue Growth: 8.35%
• EPS Growth: -136.31%
• Country: JP
• Employees: 511
• Sector: Healthcare
• Sector Strength: 41
• Industry: Medical - Devices
• EPS (TTM): -50.93
• Shares Outstanding: 26,475,880
• 10 Day Avg. Volume: 64,950
• 30 Day Avg. Volume: 92,190
• PEG Ratio: 16.23
• Price to Book (P/B): 0.58
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Japan Medical Dynamic Marketing, Inc. exhibits a strong financial position with robust revenue growth and low leverage, but faces liquidity risks due to a lack of operating cash flow. Technical indicators suggest caution due to bearish trends, although the undervaluation based on the P/E ratio and a solid dividend yield provide positive aspects for the stock.

Japan Medical Dynamic Marketing, Inc. Business Overview & Revenue Model

Company Description

Japan Medical Dynamic Marketing, Inc. (7600) is a Japanese company that operates in the medical equipment sector. It is primarily engaged in the development, manufacturing, and distribution of orthopedic products and related medical devices. The company's core offerings include surgical instruments, implants for orthopedic surgery, and other medical apparatus designed to support healthcare providers in delivering high-quality patient care.

How the Company Makes Money

Japan Medical Dynamic Marketing, Inc. generates revenue through the sale of its medical devices and orthopedic products to hospitals, clinics, and other healthcare facilities. The company has a diverse product portfolio that includes implants, surgical instruments, and various medical devices, which are distributed through a robust sales network. Key revenue streams include direct sales to healthcare institutions and partnerships with medical distributors. Additionally, the company may engage in strategic partnerships or collaborations to enhance its product offerings and expand its market reach, contributing to its overall earnings.

Japan Medical Dynamic Marketing, Inc. Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
TTM	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement		Total Revenue
24.64B	23.18B	21.31B	19.19B	16.74B	18.08B
	Gross Profit
14.93B	14.76B	13.99B	12.99B	11.42B	12.80B
	EBIT
1.79B	1.75B	2.02B	2.66B	2.17B	2.64B
	EBITDA
3.25B	3.27B	3.35B	4.21B	3.47B	4.09B
	Net Income Common Stockholders
1.42B	1.27B	1.42B	2.14B	1.66B	2.16B
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
2.33B	2.32B	2.80B	2.59B	2.47B	2.51B
	Total Assets
33.80B	31.49B	29.43B	27.34B	25.19B	24.92B
	Total Debt
2.71B	1.49B	1.87B	1.85B	3.09B	4.13B
	Net Debt
381.40M	-827.12M	-933.23M	-742.10M	623.06M	1.62B
	Total Liabilities
7.00B	5.88B	6.14B	5.85B	6.48B	7.92B
	Stockholders Equity
26.70B	25.51B	23.16B	21.39B	18.63B	16.93B
Cash Flow		Free Cash Flow
0.00	302.45M	870.67M	1.53B	1.23B	945.60M
	Operating Cash Flow
0.00	2.10B	2.19B	3.11B	2.60B	2.73B
	Investing Cash Flow
0.00	-1.80B	-1.48B	-1.75B	-1.35B	-1.79B
	Financing Cash Flow
0.00	-840.71M	-514.78M	-1.29B	-1.31B	-678.15M

Japan Medical Dynamic Marketing, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 552.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7600, the sentiment is Positive. The current price of 552 is above the 20-day moving average (MA) of 550.30, below the 50-day MA of 553.94, and below the 200-day MA of 620.39, indicating a neutral trend. The MACD of -1.65 indicates Negative momentum. The RSI at 52.41 is Neutral, neither overbought nor oversold. The STOCH value of 68.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7600.

Japan Medical Dynamic Marketing, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4568	79 Outperform	$6.49T	22.15	17.60%	1.69%	17.77%	48.97%
4543	78 Outperform	¥4.02T	34.41	8.56%	0.96%	14.23%	26.82%
6869	75 Outperform	¥1.52T	28.63	11.84%	1.23%	14.50%	29.02%
7600	74 Outperform	¥14.59B	10.23		2.72%	8.35%	-136.31%
7701	70 Outperform	$1.01T	18.76	10.72%	1.84%	4.36%	-1.76%
Sector *	52 Neutral	$5.19B	3.04	-44.64%	2.82%	16.45%	-0.53%
4544	48 Neutral	$175.31B	60.54	1.91%	3.71%	1.70%	78.07%

Japan Medical Dynamic Marketing, Inc. Corporate Events

Japan Medical Dynamic Marketing Reports Financial Discrepancy for Fiscal Year 2025

Japan Medical Dynamic Marketing, Inc. reported a discrepancy between its forecasted and actual financial results for the fiscal year ending March 2025. The company experienced a larger than expected net loss due to the decision not to recognize deferred tax assets related to litigation settlement expenses. However, it anticipates recognizing these tax effects in the next fiscal year, potentially improving future financial outcomes.

Japan Medical Dynamic Marketing Reports Fiscal Year 2025 Financial Results

Japan Medical Dynamic Marketing, Inc. reported its financial results for the fiscal year ending March 2025, showing an 8.4% increase in net sales to ¥25,114 million. However, the company faced a decline in operating and ordinary profits, and a net loss attributable to owners of the parent. The capital adequacy ratio decreased to 73.3%, and cash flow from operating activities also declined. The company plans to increase its annual dividend to ¥15.00 per share, reflecting a cautious yet optimistic outlook for the upcoming fiscal year.